FDA Warns Fertility Doctor Against Marketing Three-Parent Embryo Process for Preventing Mitochondrial Disease
The U.S. Food and Drug Administration has warned a New York fertility doctor not to market his controversial three-parent embryo procedure as a way to prevent or cure inherited mitochondrial disease. Dr. John Zhang, CEO and medical director of New Hope Fertility Center, made international headlines in 2016 when he…